Reliance Pharma Fund - Direct (D)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 16 Jan 2019 69.78 0.14
(0.20%)

NAV High-Low (in Rs)

ONE Mth 2682.96
2682.96
52-WEEk 1875.94
2752.02

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 1.18 2.18 9.77 7.6 4.08
Sensex 0.74 0.29 -0.4 3.68 48.74
Nifty 0.77 0.15 -0.93 1.08 46.62

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid 6.00 (Rs) 24-02-2018
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 31 Dec 2018
Category Share (%)
Cash & Cash Equivalent 0.00
Derivatives 0.27
Equity 97.55
Reverse Repo 2.28
› More
   As On 31 Dec 2018
Sector Name Amount
Finance & Investments 2.17
Healthcare 12.18
NA 2.55
Pharmaceuticals - Indian - Bulk Drugs 15.54
Pharmaceuticals - Indian - Bulk Drugs & Formln 55.37
Pharmaceuticals - Multinational 12.29
› More
   As On 31 Dec 2018
Company Name
Divi's Lab. 10.50
Sun Pharma.Inds. 10.11
Dr Reddy's Labs 9.26
Aurobindo Pharma 8.20
Sanofi India 6.69
Syngene Intl. 6.49
Cipla 5.81
Biocon 5.64
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-33031000/30301111 | Fax: 022-33037662

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com